Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis (vol 23, pg 596, 2017)

被引：4
|
作者：
Kalincik, T.
Jokubaitis, V
Spelman, T.
机构：
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷 / 14期
关键词：
D O I：
10.1177/1352458517735739
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oral Cladribine and Fingolimod for Relapsing Multiple Sclerosis REPLY
    Cohen, Jeffrey A.
    Kappos, Ludwig
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18): : 1739 - 1739
  • [22] Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
    Boremalm, M.
    Juto, A.
    Axelsson, M.
    Novakova, L.
    Frisell, T.
    Svenningsson, A.
    Lycke, J.
    Piehl, F.
    Selzer, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 (08) : 1060 - 1067
  • [23] Comparative efficacyof fingolimod versus natalizumab in multiple sclerosis: a prospective multicenter observational study
    Laplaud, D. A.
    Barbin, L.
    Rousseau, C.
    Jousset, N.
    Casey, R.
    Debouverie, M.
    Vukusic, S.
    De Seze, J.
    Brassat, D.
    Wiertlewski, S.
    Brochet, B.
    Pelletier, J.
    Vermersch, P.
    Edan, G.
    Lebrun-Frenay, C.
    Clavelou, P.
    Thouvenot, E.
    Camdessanche, J. -P.
    Tourbah, A.
    Stankoff, B.
    Al Khedr, A.
    Cabre, P.
    Papeix, C.
    Berger, E.
    Heinzlef, O.
    Debroucker, T.
    Moreau, T.
    Gout, O.
    Bourre, B.
    Creange, A.
    Labauge, P.
    Magy, L.
    Defer, G.
    Foucher, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 62 - 63
  • [24] Natalizumab and multiple sclerosis (vol 61, pg 234, 2003)
    Michailowsky, C.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (08) : I - I
  • [25] Natalizumab and multiple sclerosis (vol 71, pg 135, 2013)
    Pimentel, M. L., V
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2013, 71 (06) : I - I
  • [26] Indirect comparisons of oral fingolimod versus natalizumab and cladribine for the treatment of relapsing-remitting multiple sclerosis based on data from FREEDOMS, AFFIRM and CLARITY
    Nixon, R.
    Eckert, B.
    Cutter, G.
    Mercier, F.
    Francis, G.
    Kappos, L.
    JOURNAL OF NEUROLOGY, 2012, 259 : S68 - S68
  • [27] ECONOMIC EVALUATION OF NATALIZUMAB VERSUS FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SWEDEN
    Alexopoulos, S. T.
    Deniz, B.
    Walker, A. R.
    Arnold, R.
    Bates, D.
    VALUE IN HEALTH, 2012, 15 (04) : A145 - A145
  • [28] Fingolimod/natalizumab withdrawalRebound multiple sclerosis: 2 case reports
    Reactions Weekly, 2016, 1623 (1) : 93 - 93
  • [29] Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
    Unsal, Mirac Aysen
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (01) : 50 - 51
  • [30] Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
    Chitnis, Tanuja
    Arnold, Douglas L.
    Banwell, Brenda
    Brueck, Wolfgang
    Ghezzi, Angelo
    Giovannoni, Gavin
    Greenberg, Benjamin
    Krupp, Lauren
    Rostasy, Kevin
    Tardieu, Marc
    Waubant, Emmanuelle
    Wolinsky, Jerry S.
    Bar-Or, Amit
    Stites, Tracy
    Chen, Yu
    Putzki, Norman
    Merschhemke, Martin
    Gaertner, Jutta
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1017 - 1027
12345